ChoA Pharmaceutical Co.Ltd (034940) — Capital Reinvestment Ratio

Latest as of September 2025: 0.26x

ChoA Pharmaceutical Co.Ltd (034940) has a Capital Reinvestment Ratio of 0.26x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩1.26 Billion) in capital expenditures (₩324.67 Million). See debt-free asset ratio of ChoA Pharmaceutical Co.Ltd to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.26x
Capex / Operating Cash Flow

Operating Cash Flow

₩1.26 Billion
KRW

Capital Expenditures

₩324.67 Million
KRW

Data as of

Sep 2025
Most recent filing

ChoA Pharmaceutical Co.Ltd Capital Reinvestment Ratio (2004–2020)

This chart tracks ChoA Pharmaceutical Co.Ltd's Capital Reinvestment Ratio across 8 annual periods. Check 034940 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for ChoA Pharmaceutical Co.Ltd (2004–2020)

Year-by-year Capital Reinvestment Ratio for ChoA Pharmaceutical Co.Ltd from 2004 to 2020. For live market cap and broader valuation context, see ChoA Pharmaceutical Co.Ltd market capitalisation.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2020 1.87x ₩1.92 Billion ₩3.60 Billion ▲ +460.2%
2019 0.33x ₩4.16 Billion ₩1.39 Billion ▼ -65.4%
2018 0.96x ₩2.04 Billion ₩1.97 Billion ▼ -60.9%
2016 2.47x ₩930.42 Million ₩2.30 Billion ▲ +64.4%
2015 1.50x ₩1.19 Billion ₩1.78 Billion ▼ -83.3%
2014 9.02x ₩625.52 Million ₩5.64 Billion ▲ +2884.8%
2013 0.30x ₩3.53 Billion ₩1.07 Billion ▲ +110.8%
2004 0.14x ₩3.57 Billion ₩512.47 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow